A pharmaceutical company has issued a voluntary recall of over 3 million of its over-the-counter eye-drop products after the Food and Drug Administration cited a “lack of assurance of sterility.”According to the FDA notice, K.C.

Author: Kaan Ozcan

This post was originally published on NBC News.